business

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Yahoo Finance · Jun 22, 2026, 2:35 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Bloomberg Markets AbbVie to Buy Apogee Therapeutics for $10.9 Billion Investing.com AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says STAT News STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Also covered by

More in business